Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery

Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also...

Full description

Saved in:
Bibliographic Details
Published inBMC surgery Vol. 24; no. 1; pp. 416 - 11
Main Authors Takahashi, Makoto, Sakamoto, Kazuhiro, Ro, Hisashi, Kochi, Saki, Toake, Miyuki, Takahashi, Hiromitsu, Irie, Takahiro, Momose, Hirotaka, Amemiya, Kota, Tsuchiya, Yuki, Tsukamoto, Ryoichi, Honjo, Kumpei, Kawai, Masaya, Ishiyama, Shun, Sugimoto, Kiichi, Kojima, Yutaka
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 23.12.2024
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN1471-2482
1471-2482
DOI10.1186/s12893-024-02697-5

Cover

Loading…
Abstract Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
AbstractList BackgroundLateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.MethodsThe subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.ResultsOf the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.ConclusionsThere was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.BACKGROUNDLateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.METHODSThe subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.RESULTSOf the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.CONCLUSIONSThere was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. The subjects were 100 patients with LARC ([greater than or equal to] cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at [less than or equal to] 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
Abstract Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. Methods The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Results Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. Conclusions There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. Methods The subjects were 100 patients with LARC ([greater than or equal to] cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at [less than or equal to] 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Results Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. Conclusions There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. Keywords: Lateral lymph node resection, Urinary dysfunction, Removal of urinary catheter, Duration of urinary catheterization, Robot-assisted laparoscopic surgery, Laparoscopic surgery, Rectal cancer
Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.
ArticleNumber 416
Audience Academic
Author Irie, Takahiro
Ro, Hisashi
Honjo, Kumpei
Takahashi, Makoto
Takahashi, Hiromitsu
Tsukamoto, Ryoichi
Kojima, Yutaka
Sugimoto, Kiichi
Kawai, Masaya
Toake, Miyuki
Kochi, Saki
Sakamoto, Kazuhiro
Ishiyama, Shun
Tsuchiya, Yuki
Amemiya, Kota
Momose, Hirotaka
Author_xml – sequence: 1
  givenname: Makoto
  surname: Takahashi
  fullname: Takahashi, Makoto
– sequence: 2
  givenname: Kazuhiro
  surname: Sakamoto
  fullname: Sakamoto, Kazuhiro
– sequence: 3
  givenname: Hisashi
  surname: Ro
  fullname: Ro, Hisashi
– sequence: 4
  givenname: Saki
  surname: Kochi
  fullname: Kochi, Saki
– sequence: 5
  givenname: Miyuki
  surname: Toake
  fullname: Toake, Miyuki
– sequence: 6
  givenname: Hiromitsu
  surname: Takahashi
  fullname: Takahashi, Hiromitsu
– sequence: 7
  givenname: Takahiro
  surname: Irie
  fullname: Irie, Takahiro
– sequence: 8
  givenname: Hirotaka
  surname: Momose
  fullname: Momose, Hirotaka
– sequence: 9
  givenname: Kota
  surname: Amemiya
  fullname: Amemiya, Kota
– sequence: 10
  givenname: Yuki
  surname: Tsuchiya
  fullname: Tsuchiya, Yuki
– sequence: 11
  givenname: Ryoichi
  surname: Tsukamoto
  fullname: Tsukamoto, Ryoichi
– sequence: 12
  givenname: Kumpei
  surname: Honjo
  fullname: Honjo, Kumpei
– sequence: 13
  givenname: Masaya
  surname: Kawai
  fullname: Kawai, Masaya
– sequence: 14
  givenname: Shun
  surname: Ishiyama
  fullname: Ishiyama, Shun
– sequence: 15
  givenname: Kiichi
  surname: Sugimoto
  fullname: Sugimoto, Kiichi
– sequence: 16
  givenname: Yutaka
  surname: Kojima
  fullname: Kojima, Yutaka
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39716123$$D View this record in MEDLINE/PubMed
BookMark eNptkltvFCEYhiemxh70D3hhSLzxZiqHYYAr0zQemjTRC70mLDBbNgysMLNm_PV-7ba1awwhfIGHF154T5ujlJNvmtcEnxMi-_eVUKlYi2kHvVei5c-aE9IJ0tJO0qMn9XFzWusGYyIk5y-aY6YE6QllJ83vb7lOeeuLmcLOo7mEZMqC3FKHOdkp5ISGHGP-FdIaRTMBGFFcxu0NStl55EKt_oErqEANgDXJ-oJ2waAxpDCaGBcU0s7U20PqXNa-LC-b54OJ1b-6H8-aH58-fr_80l5__Xx1eXHdWk741BrTOzsMnBlqjXW0F1ww550Ug-MY92CpF4KpQSlFpMCcWkwkddwxhzkh7Ky52uu6bDZ6W-A6ZdHZBH03kctamzIFG73uQMELMii6Mp2wfkU6rrD0jDFOOmVB68NeazuvRu-sTxM8yIHo4UoKN3qdd5qQvu8kp6Dw7l6h5J-zr5MeQ7U-RpN8nqtmpJOyI7LrAX37D7rJc0nwVkBx-HHwrf5SawMOQhoyHGxvRfWFpOBfKC6BOv8PBc35MVjI1RBg_mDDm6dOHy0-RAcAugdsybUWPzwiBOvbfOp9PjXkU9_lU3P2BzqE2E0
Cites_doi 10.1007/s00464-017-5948-4
10.1007/s00268-015-3299-7
10.1007/s00384-021-03858-1
10.1111/ans.18029
10.1007/s00268-016-3762-0
10.1007/s00268-016-3444-y
10.1093/bjsopen/zrae048
10.1007/s10151-020-02383-7
10.21037/jgo.2019.10.03
10.1007/s00464-020-07943-4
10.1097/01.sla.0000133083.54934.ae
10.1007/s00464-021-08364-7
10.1016/j.asjsur.2020.06.010
10.1007/s13193-017-0698-2
10.1097/SLA.0000000000002212
10.23922/jarc.2019-018
10.1002/bjs.11513
10.1007/s00384-016-2640-4
10.1016/j.critrevonc.2023.104196
10.3389/fsurg.2019.00079
10.1016/j.amjsurg.2023.10.046
10.1055/s-0040-1714238
10.1111/ases.13192
10.3892/ol.2024.14214
10.1002/bjs5.50194
10.3748/wjg.v26.i21.2877
10.1016/S0022-3468(97)90702-8
10.1093/jjco/hyac167
10.1245/s10434-021-10312-7
10.1097/DCR.0b013e31822c94e6
10.1007/s00464-020-07979-6
10.1016/j.anclin.2009.07.010
10.1007/s11605-021-05035-9
10.1097/SLE.0000000000000681
10.1007/s00464-024-10901-z
10.4993/acrt.30.106
10.5980/jpnjurol1989.80.1257
10.3855/jidc.15289
10.1371/journal.pone.0304031
10.1007/s00464-024-11111-3
10.3862/jcoloproctology.72.373
10.1007/s11605-020-04825-x
ContentType Journal Article
Copyright 2024. The Author(s).
COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7QP
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
M0S
M1P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12893-024-02697-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central - New (Subscription)
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1471-2482
EndPage 11
ExternalDocumentID oai_doaj_org_article_4918e71f92ba47ceb145908e3335149c
PMC11664852
A821137958
39716123
10_1186_s12893_024_02697_5
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QO
7QP
7XB
8FD
8FK
AZQEC
DWQXO
FR3
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-aa6dcff53a2cacd267573ded87fd500678567739f999187052c0182d5d3d05113
IEDL.DBID M48
ISSN 1471-2482
IngestDate Wed Aug 27 01:25:49 EDT 2025
Thu Aug 21 18:30:12 EDT 2025
Mon Jul 21 11:53:20 EDT 2025
Fri Jul 25 22:44:59 EDT 2025
Tue Jun 17 22:00:00 EDT 2025
Tue Jun 10 21:05:55 EDT 2025
Wed Feb 19 01:59:11 EST 2025
Tue Jul 01 01:18:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Duration of urinary catheterization
Rectal cancer
Robot-assisted laparoscopic surgery
Removal of urinary catheter
Laparoscopic surgery
Urinary dysfunction
Lateral lymph node resection
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-aa6dcff53a2cacd267573ded87fd500678567739f999187052c0182d5d3d05113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/3152696779?pq-origsite=%requestingapplication%
PMID 39716123
PQID 3152696779
PQPubID 42548
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_4918e71f92ba47ceb145908e3335149c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11664852
proquest_miscellaneous_3148841846
proquest_journals_3152696779
gale_infotracmisc_A821137958
gale_infotracacademiconefile_A821137958
pubmed_primary_39716123
crossref_primary_10_1186_s12893_024_02697_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-23
PublicationDateYYYYMMDD 2024-12-23
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-23
  day: 23
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC surgery
PublicationTitleAlternate BMC Surg
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References T Akiyoshi (2697_CR39) 2019; 3
YC Chen (2697_CR28) 2024; 38
G Wakabayashi (2697_CR42) 1997; 52
2697_CR3
2697_CR15
K Erozkan (2697_CR12) 2024; 230
R Du (2697_CR25) 2021; 44
S Fujita (2697_CR8) 2017; 266
HJ Kim (2697_CR30) 2018; 32
S Tsuchida (2697_CR36) 1989; 80
Y Kanemitsu (2697_CR33) 2020; 33
K Kawai (2697_CR35) 2023; 93
A Ishibe (2697_CR2) 2016; 40
J Otero de Pablos (2697_CR5) 2019; 6
T Shigaki (2697_CR22) 2019; 72
SH Song (2697_CR29) 2021; 25
K Koushi (2697_CR47) 2016; 31
R Flouchi (2697_CR44) 2022; 16
H Kawamura (2697_CR32) 2022; 30
JN Chen (2697_CR40) 2020; 26
2697_CR34
S Zhou (2697_CR19) 2023; 53
K Li (2697_CR43) 2021; 25
D Fernández-Martínez (2697_CR17) 2020; 11
RA Wani (2697_CR18) 2017; 8
2697_CR31
S Tsukamoto (2697_CR9) 2020; 107
A Hamabe (2697_CR13) 2024; 8
D Dindo (2697_CR14) 2004; 240
Y Sadakari (2697_CR21) 2022; 36
L Boublikova (2697_CR7) 2023; 192
H Morohashi (2697_CR26) 2021; 35
MA Chaouch (2697_CR20) 2024; 19
B Zou (2697_CR23) 2024; 27
T Manabe (2697_CR38) 2019; 29
K Hida (2697_CR11) 2021; 28
MR Davies (2697_CR37) 1997; 32
Y Nishizawa (2697_CR46) 2011; 54
J Watanabe (2697_CR24) 2021; 35
L Wang (2697_CR16) 2021; 25
DM Darrah (2697_CR48) 2009; 27
AA Iv (2697_CR6) 2022; 35
H Inoue (2697_CR4) 2021; 36
H Nishi (2697_CR45) 2021; 69
T Kinugasa (2697_CR1) 2013; 33
M Obatake (2697_CR27) 2023; 16
A Ogura (2697_CR41) 2017; 41
H Ozawa (2697_CR10) 2016; 40
References_xml – volume: 32
  start-page: 2466
  issue: 5
  year: 2018
  ident: 2697_CR30
  publication-title: Surg Endosc
  doi: 10.1007/s00464-017-5948-4
– volume: 40
  start-page: 995
  issue: 4
  year: 2016
  ident: 2697_CR2
  publication-title: World J Surg
  doi: 10.1007/s00268-015-3299-7
– volume: 36
  start-page: 1263
  issue: 6
  year: 2021
  ident: 2697_CR4
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-021-03858-1
– volume: 93
  start-page: 206
  issue: 1–2
  year: 2023
  ident: 2697_CR35
  publication-title: ANZ J Surg
  doi: 10.1111/ans.18029
– volume: 41
  start-page: 868
  issue: 3
  year: 2017
  ident: 2697_CR41
  publication-title: World J Surg
  doi: 10.1007/s00268-016-3762-0
– volume: 40
  start-page: 1492
  issue: 6
  year: 2016
  ident: 2697_CR10
  publication-title: World J Surg
  doi: 10.1007/s00268-016-3444-y
– volume: 8
  start-page: zrae048
  issue: 3
  year: 2024
  ident: 2697_CR13
  publication-title: BJS Open
  doi: 10.1093/bjsopen/zrae048
– volume: 25
  start-page: 413
  issue: 4
  year: 2021
  ident: 2697_CR29
  publication-title: Tech Coloproctol
  doi: 10.1007/s10151-020-02383-7
– volume: 11
  start-page: 91
  issue: 1
  year: 2020
  ident: 2697_CR17
  publication-title: J Gastrointest Oncol
  doi: 10.21037/jgo.2019.10.03
– volume: 35
  start-page: 4427
  issue: 8
  year: 2021
  ident: 2697_CR24
  publication-title: Surg Endosc
  doi: 10.1007/s00464-020-07943-4
– volume: 240
  start-page: 205
  issue: 2
  year: 2004
  ident: 2697_CR14
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000133083.54934.ae
– volume: 36
  start-page: 999
  issue: 2
  year: 2022
  ident: 2697_CR21
  publication-title: Surg Endosc
  doi: 10.1007/s00464-021-08364-7
– volume: 44
  start-page: 26
  issue: 1
  year: 2021
  ident: 2697_CR25
  publication-title: Asian J Surg
  doi: 10.1016/j.asjsur.2020.06.010
– volume: 8
  start-page: 499
  issue: 4
  year: 2017
  ident: 2697_CR18
  publication-title: Indian J Surg Oncol
  doi: 10.1007/s13193-017-0698-2
– volume: 266
  start-page: 201
  issue: 2
  year: 2017
  ident: 2697_CR8
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000002212
– volume: 33
  start-page: 2921
  issue: 7
  year: 2013
  ident: 2697_CR1
  publication-title: Anticancer Res
– ident: 2697_CR3
  doi: 10.23922/jarc.2019-018
– volume: 107
  start-page: 586
  issue: 5
  year: 2020
  ident: 2697_CR9
  publication-title: Br J Surg
  doi: 10.1002/bjs.11513
– volume: 31
  start-page: 1845
  issue: 12
  year: 2016
  ident: 2697_CR47
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-016-2640-4
– volume: 192
  start-page: 104196
  year: 2023
  ident: 2697_CR7
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2023.104196
– volume: 6
  start-page: 79
  year: 2019
  ident: 2697_CR5
  publication-title: Front Surg
  doi: 10.3389/fsurg.2019.00079
– volume: 230
  start-page: 91
  year: 2024
  ident: 2697_CR12
  publication-title: Am J Surg
  doi: 10.1016/j.amjsurg.2023.10.046
– volume: 33
  start-page: 349
  issue: 6
  year: 2020
  ident: 2697_CR33
  publication-title: Clin Colon Rectal Surg
  doi: 10.1055/s-0040-1714238
– ident: 2697_CR34
– volume: 16
  start-page: 455
  issue: 3
  year: 2023
  ident: 2697_CR27
  publication-title: Asian J Endosc Surg
  doi: 10.1111/ases.13192
– volume: 27
  start-page: 80
  issue: 2
  year: 2024
  ident: 2697_CR23
  publication-title: Oncol Lett
  doi: 10.3892/ol.2024.14214
– volume: 3
  start-page: 822
  issue: 6
  year: 2019
  ident: 2697_CR39
  publication-title: BJS Open
  doi: 10.1002/bjs5.50194
– volume: 69
  start-page: 216
  year: 2021
  ident: 2697_CR45
  publication-title: Jpn J Occup Med Traumatol
– ident: 2697_CR15
– volume: 26
  start-page: 2877
  issue: 21
  year: 2020
  ident: 2697_CR40
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v26.i21.2877
– volume: 32
  start-page: 536
  issue: 4
  year: 1997
  ident: 2697_CR37
  publication-title: J Pediatr Surg
  doi: 10.1016/S0022-3468(97)90702-8
– volume: 35
  start-page: 226
  issue: 3
  year: 2022
  ident: 2697_CR6
  publication-title: Ann Gastroenterol
– volume: 53
  start-page: 26
  issue: 1
  year: 2023
  ident: 2697_CR19
  publication-title: Jpn J Clin Oncol
  doi: 10.1093/jjco/hyac167
– volume: 28
  start-page: 6179
  issue: 11
  year: 2021
  ident: 2697_CR11
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-021-10312-7
– volume: 52
  start-page: 575
  year: 1997
  ident: 2697_CR42
  publication-title: J Clin Surg
– volume: 54
  start-page: 1423
  issue: 11
  year: 2011
  ident: 2697_CR46
  publication-title: Dis Colon Rectum
  doi: 10.1097/DCR.0b013e31822c94e6
– volume: 35
  start-page: 5001
  issue: 9
  year: 2021
  ident: 2697_CR26
  publication-title: Surg Endosc
  doi: 10.1007/s00464-020-07979-6
– volume: 27
  start-page: 465
  issue: 3
  year: 2009
  ident: 2697_CR48
  publication-title: Anesthesiol Clin
  doi: 10.1016/j.anclin.2009.07.010
– volume: 25
  start-page: 2726
  issue: 10
  year: 2021
  ident: 2697_CR43
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-021-05035-9
– volume: 29
  start-page: 493
  issue: 6
  year: 2019
  ident: 2697_CR38
  publication-title: Surg Laparosc Endosc Percutan Tech
  doi: 10.1097/SLE.0000000000000681
– volume: 38
  start-page: 3520
  issue: 7
  year: 2024
  ident: 2697_CR28
  publication-title: Surg Endosc
  doi: 10.1007/s00464-024-10901-z
– volume: 30
  start-page: 106
  issue: 2
  year: 2022
  ident: 2697_CR32
  publication-title: Ann Cancer Res Ther
  doi: 10.4993/acrt.30.106
– volume: 80
  start-page: 1257
  issue: 9
  year: 1989
  ident: 2697_CR36
  publication-title: Jpn J Urol
  doi: 10.5980/jpnjurol1989.80.1257
– volume: 16
  start-page: 1191
  issue: 7
  year: 2022
  ident: 2697_CR44
  publication-title: J Infect Dev Ctries
  doi: 10.3855/jidc.15289
– volume: 19
  start-page: e0304031
  issue: 5
  year: 2024
  ident: 2697_CR20
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0304031
– ident: 2697_CR31
  doi: 10.1007/s00464-024-11111-3
– volume: 72
  start-page: 373
  issue: 6
  year: 2019
  ident: 2697_CR22
  publication-title: J Jpn Soc Coloproctol
  doi: 10.3862/jcoloproctology.72.373
– volume: 25
  start-page: 1866
  issue: 7
  year: 2021
  ident: 2697_CR16
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-020-04825-x
SSID ssj0017855
Score 2.3572316
Snippet Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some...
Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there...
BackgroundLateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there...
Abstract Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 416
SubjectTerms Abdomen
Adult
Aged
Aged, 80 and over
Cancer
Cancer surgery
Cancer therapies
Catheterization
Catheters
Colorectal cancer
Complications
Dissection
Duration of urinary catheterization
Female
Health aspects
Humans
Intubation
Laparoscopic surgery
Laparoscopy
Laparoscopy - adverse effects
Laparoscopy - methods
Lateral lymph node resection
Lymph Node Excision - adverse effects
Lymph Node Excision - methods
Lymph nodes
Lymphatic system
Male
Medical instruments
Metastasis
Middle Aged
Minimally invasive surgery
Multivariate analysis
Patients
Postoperative
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Postoperative Complications - prevention & control
Rectal Neoplasms - surgery
Rectum
Removal of urinary catheter
Retrospective Studies
Risk Factors
Robot-assisted laparoscopic surgery
Robotic surgery
Robotic Surgical Procedures - adverse effects
Robotic Surgical Procedures - methods
Surgical site infections
Urinary Catheterization
Urinary dysfunction
Urination Disorders - epidemiology
Urination Disorders - etiology
Urination Disorders - prevention & control
Urine
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixNBEG5kT15E8TW6SguCBxk2_e4-ruKyCHpyYW9NTz8wMM4sSXaX-OutmkfI4MGLh1zSFZiud2WqviLkfRJSNDzmOluxqqUNsnaR6bppsjTCpmIZzg5_-64vr-TXa3V9tOoLe8JGeOCRcWfSMZsNK443QZoIrkXimu4sBPagu4jeF2LeXExN7w-MVWoekbH6bAteGPvUuISPdqZWizA0oPX_7ZOPgtKyYfIoAl08Jo-m1JGej4_8hDzI3VPyG7ft9jd5BPCm-N952Oxp2m8xYiHXaQFR9_cQomgbcN64pe0eZEi7PmU6vI-f6TYU_R8QRNSFDb1bB4rYI79C2-7pursL2OxOt-Mo9TNydfHlx-fLetqnUEfIWnZ1CDrFUpQIPIaYONQKRqScrClJDWFLaWOEK5g0gh0rHldQfiSVRALbZeI5Oen6Lr8k1CQhtAtNRrAYWQyIVudViJyVpFnhFfk4s9ffjLAZfig3rPajMDwIww_C8Koin1ACB0qEvB6-AEXwkyL4fylCRT6g_DwaJggJbjjOF8ADI8SVP7dQ6wrjlK3I6YISDCouj2cN8JNBb71guIod2OMq8u5wjL_EJrUu97dIA95QQsmsK_JiVJjDlQRCdUGWUBG7UKXFnZcn3frnAPfNmNbSKv7qf3DpNXnI0QwYr7k4JSe7zW1-A2nVrnk7WNAfGMAg6A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Li9RAEG50vXgRxVd0lRYEDxJ20u-cZBWXRdCTC3NrOv3QgZiMyewus7_eqjzGDYKHXNIV6O56dXWqviLkbeCCV8zHPBq-yoVxIi99ofKqikJzE5IpsHb46zd1fiG-rOV6unDrp7TK2SYOhjq0Hu_IT3iBvbCV1uWH7e8cu0bh39WphcZdcg-hyzD40utDwIWN5-VcKGPUSQ-2GLPVmIBHlTqXC2c0YPb_a5lvuaZl2uQtP3T2kDyYDpD0dOT4I3InNo_JDfbcbbdxhPGmeIPuuj0N-x79Fu49TcDw9hocFa0dVh3XtN4DJ2nThkiHv_IzXUfRCgKBR4no6NXGUUQg-eXqek83zZXDlHfajwXVT8jF2efvn87zqatC7uHsssudU8GnJLlj3vnAIGLQPMRgdApycF4SdpmXCY-OoM2S-RUEIUEGHkCDC_6UHDVtE58TqgPnqnRVRMgYkTQwWMWV86xIQRWJZeT9vL12O4Jn2CHoMMqOzLDADDsww8qMfEQOHCgR-Hp40XY_7KRHVsCcoi5SySontAdPI7Bre-QcSxJKn5F3yD-L6glMghWOVQYwYQS6sqcGIl6uS2kycrygBLXyy-FZAuyk1r39K4QZeXMYxi8xVa2J7SXSgE0UEDirjDwbBeawJI6AXXBWyIhZiNJizcuRZvNzAP0uCqWEkezF_-f1ktxnKOAFyxk_Jke77jK-gmPTrno96MYfY0kZeg
  priority: 102
  providerName: ProQuest
Title Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery
URI https://www.ncbi.nlm.nih.gov/pubmed/39716123
https://www.proquest.com/docview/3152696779
https://www.proquest.com/docview/3148841846
https://pubmed.ncbi.nlm.nih.gov/PMC11664852
https://doaj.org/article/4918e71f92ba47ceb145908e3335149c
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3da9RAEF_6AdIXUfyK1mMFwQeJXvY7DyI9aSlCixQPDl-Wze6mHsSc5q7V8693JrmcDdaH5CE7Cdn9_WZnJ9mZIeRl4IIXzMc0Gj5OhXEizX2m0qKIQnMTSpNh7PDZuTqdio8zOdshfbmjzQAub3XtsJ7UtKne_Pqxfg8K_65VeKPeLmGOxV1oTMChcp3KXbIPlkljKYcz8fevgjZS9oEzt953QO5wzKmUMT6wU206_38n7RtWa7ij8oaJOrlH7m7WlvSoI8N9shPrB-Q3luOFPnUZvil-XHfNmob1Ek0awkJL4MLiJ9gwWjkMSK5otQaQab0IkbY_7Hu5huIECQIeydLQ67mjmJzkm6uqNZ3X1w53w9NlF2v9kExPjj9_OE03BRdSD8uaVeqcCr4sJXfMOx8YOBOahxiMLoNs7ZpUWvO8xFUlKLpkfgz-SZCBB1DujD8ie_Wijk8I1YFzlbsiYjYZUWrAXsWx8ywrg8pKlpDX_fDa711eDdv6I0bZDhcLuNgWFysTMkEEtpKYE7u9sGgu7UbFrIB3ijorc1Y4oT0YIYEF3SPnGK2Q-4S8QvwscglAgh52AQjwwpgDyx4ZcIa5zqVJyOFAEjTOD5t7BtiesJZnWKsdhidPyIttM96Ju9jquLhCGZguBfjUKiGPO8Jsu9TzLiFmQKVBn4ct9fxrmw88y5QSRrKn_33oM3LAkOYZSxk_JHur5io-h8XUqhiRXT3TI7I_OT7_dDFqP0mMWq2B88Xkyx-CHCDs
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gAXBOIVKGAkEAcUdeNnckCohVZb2q4QaqXejGM7ZaWQLLvbVsuP4jcyk2yWRkjcesglHie25_PMOJkHIa89FzxnLsQh5cNYpFbEmUtUnOdBaJ76Ik0wdvh4rEan4vOZPNsgv7tYGHSr7GRiI6h97fAb-TZPsBa20jr7MP0ZY9Uo_LvaldBoYXEYlldwZJu_P_gE_H3D2P7eycdRvKoqEDvQ3YvYWuVdUUhumbPOM7CYNffBp7rwshHeEt7CswJNJ0CzZG4IRriXnntAcMLhubfIpuBgKgzI5u7e-MvX9X8L6Cy70JxUbc9B-qN_HBNwqUzHsqf-mioB_-qCa8qw76h5TfPt3yN3VyYr3Wkxdp9shOoB-YVVfutpaBOHU_xmb2dL6pdz1JTIbVoAxOorUI20tBjnXNJyCdihVe0DbfwAOroZRbkLBA4xOKOXE0sx58kPW5ZLOqkuLTrZ03kbwv2QnN7Iij8ig6quwhNCtedcZTYPmKRGFBogpcLQOpYUXiUFi8i7bnnNtE3XYZpjTqpMywwDzDANM4yMyC5yYE2JqbabG_Xs3Kx2rhEwpqCTImO5FdqBbhNYJz5wjkEQmYvIW-SfQYEATIIZtnENMGBMrWV2Ujhjc53JNCJbPUrYyK7f3CHArATJ3PyFfURerZuxJzrHVaG-QBqQwgKO6ioij1vArKfEMUUYWCcRSXtQ6s2531JNvjdpxpNEKZFK9vT_43pJbo9Ojo_M0cH48Bm5wxDsCYsZ3yKDxewiPAejbZG_WO0USr7d9Ob8A4UPVn0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Postoperative+urinary+dysfunction+following+lateral+lymph+node+dissection+for+rectal+cancer+via+minimally+invasive+surgery&rft.jtitle=BMC+surgery&rft.au=Takahashi%2C+Makoto&rft.au=Sakamoto%2C+Kazuhiro&rft.au=Ro%2C+Hisashi&rft.au=Kochi%2C+Saki&rft.date=2024-12-23&rft.eissn=1471-2482&rft.volume=24&rft.issue=1&rft.spage=416&rft_id=info:doi/10.1186%2Fs12893-024-02697-5&rft_id=info%3Apmid%2F39716123&rft.externalDocID=39716123
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2482&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2482&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2482&client=summon